Analgesics - Netherlands | Statista Market Forecast

In the Netherlands, the revenue in the Analgesics market is estimated to reach US$211.00m in 2024.
It is projected that the market will experience an annual growth rate of 4.41% (CAGR 2024-2029).
When compared globally, the United States generates the highest revenue in this market, with US$7.24bn in 2024.
Taking into account the total population, the per person revenue in the Netherlands is US$11.94 in 2024.
The Netherlands is experiencing a growing demand for natural and herbal analgesics in the OTC Pharmaceuticals market.

Definition:
The Analgesics market comprises over-the-counter natural and synthetic non-opioid analgesics (only in approved low doses) like Paracetamol, Ibuprofen, Aspirin, Diclofenac and other pain-relieving preparations. Legislation on opioid analgesics differs from country to country. According to the respective state legislation, legal opioid analgesics are included. In Germany, Austria and Switzerland, for instance, opioid analgesics are only included if they are not limited by the narcotics law and do not require prescription. Analgesics are included in the form of pills, capsules, gels and ointments. Not included are prescription medicines (e.g. morphine), anesthetics and homeopathic remedies. Among the top-selling painkillers are Voltaren, Aspirin, Thomapyrin, Ibuprofen, Dolormin, Paracetamol and ASS. It includes both products which are exclusively sold in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Additional information:
The Analgesics market comprises revenues, average revenue per capita. Sales channels show online and offline revenue. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Over-the-counter analgesics (e.g. Aspirin and Paracetamol)
Natural and synthetic agents
In the form of pills, capsules, gels and ointments

Prescription medicines
Homeopathic remedies
Anesthetics

The Analgesics market in Netherlands has been experiencing steady growth in recent years.

Customer preferences: Customers in Netherlands have shown a strong preference for over-the-counter analgesic products. This is driven by the convenience and accessibility of these products, as well as the increasing awareness of self-care and self-medication. Moreover, customers in Netherlands are increasingly seeking natural and organic analgesic products, reflecting a growing trend towards health and wellness.

Trends in the market: One of the key trends in the Analgesics market in Netherlands is the rising demand for non-opioid analgesics. This can be attributed to the growing concerns over the addictive properties and side effects of opioid-based pain medications. As a result, customers are seeking alternative pain relief options that are safer and have fewer adverse effects.Another trend in the market is the increasing popularity of topical analgesics. These products are applied directly to the skin and provide localized pain relief. They are preferred by customers who want targeted pain relief without the systemic effects of oral analgesics. The convenience and ease of application of topical analgesics also contribute to their rising popularity.

Local special circumstances: The Netherlands has a well-developed healthcare system that emphasizes patient empowerment and self-care. This has created a favorable environment for the growth of the Analgesics market, as customers are encouraged to take responsibility for their own health and well-being. The country also has a high level of health literacy, with customers being well-informed about different treatment options and actively seeking out products that align with their preferences and values.

Underlying macroeconomic factors: The strong economic performance of Netherlands has played a significant role in the growth of the Analgesics market. With a stable economy and high disposable incomes, customers have the financial means to purchase analgesic products. Moreover, the aging population in Netherlands has contributed to the increasing demand for analgesics, as older individuals are more likely to experience chronic pain and require pain management solutions.In conclusion, the Analgesics market in Netherlands is experiencing steady growth driven by customer preferences for over-the-counter products, the rising demand for non-opioid analgesics, and the increasing popularity of topical analgesics. The local special circumstances, such as the emphasis on self-care and the high level of health literacy, further support the growth of the market. Additionally, the strong macroeconomic factors, including the stable economy and aging population, contribute to the increasing demand for analgesic products in Netherlands.

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

The global pharmaceutical industry has experienced significant growth during the past two decades, with revenues totaling around 1.6 trillion U.S. dollars in 2023. With growth like that, the industry's size is now comparable to the gross domestic products (GDPs) of countries like Spain, Mexico, or Australia.